Comparative effects of sotalol and propranolol on contractility of papillary muscles and adenyl cyclase activity of myocardial extracts of cat.

No abstract is available for this paper.

• Publication year

  1972

• Venue

  The Journal of New Drugs

• Publication date

  1972-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/J.1552-4604.1972.TB00041.XPMID 4401703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM

  1997cited by this paper
• Adenyl Cyclase and Cyclic AMP: Biochemical Links in the Regulation of Myocardial Contractility

  1971cited by this paper
• The role of cyclic 3'5'-AMP in the cardiac response to adrenaline.

  1970cited by this paper
• Clinical evaluation of the antiarrhythmic effects of Sotalol® (MJ 1999)

  1970cited by this paper
• Electrophysiological and Beta‐Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue

  1970cited by this paper
• Adenyl cyclase in cardiac tissue.

  1970cited by this paper
• On the biological role of cyclic AMP.

  1970cited by this paper
• Isolation of cyclic 3',5'-adenosine monophosphate on a neutral silicic acid-glass microfiber matrix.

  1970cited by this paper
• Sotalol‐Induced Beta Blockade in Cardiac Patients

  1970cited by this paper
• Relation between mechanics of contraction and relaxation in mammalian cardiac muscle.

  1969cited by this paper
• Dissociation of the increased formation of cardiac adenosine 3',5'-monophosphate from the positive inotropic effect of norepinephrine.

  1969cited by this paper
• Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.

  1968cited by this paper
• ANTIARRUYTHMIC ACTIVITY OF THE DEXTRO- AND LEVO-ROTATORY ISOMERS OF 4-(2-ISOPROPYLAMINO-1-HYDROXYETHYL) METHANESULFONANILIDE (MJ 1999)

  1968cited by this paper
• Effects of Propranolol on the Transmembrane Potentials of Ventricular Muscle and Purkinje Fibers of the Dog

  1968cited by this paper
• Sotalol: a new, safe beta adrenergic receptor blocking agent.

  1968cited by this paper
• Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.

  1967cited by this paper
• APPRAISAL OF THE EFFECTS OF CATECHOLAMINES ON CARDIAC ELECTRICAL ACTIVITY *

  1967cited by this paper
• Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.

  1967cited by this paper
• A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.

  1967cited by this paper
• Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.

  1967cited by this paper
• EVALUATION OF THE CARDIAC EFFECTS OF SEVERAL BETA ADRENERGIC BLOCKING AGENTS

  1967cited by this paper
• Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships.

  1966cited by this paper
• Blockade of epinephrine- and ouabain-induced cardiac arrhythmias in the dog heart-lung preparation.

  1966cited by this paper
• Antagonism of epinephrine-induced cardiac arrhythmias by 4-(2-isopropylamino-1-hydroxyethyl)-methanesulfonanilide (MJ 1999) .

  1966cited by this paper
• Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

  1965cited by this paper
• Inotropic and metabolic effects of three beta-adrenergic receptor blocking drugs on isolated rabbit left atria.

  1965cited by this paper
• Dissociation of the augmentation of cardiac contractile force from the activation of myocardial phosphorylase by catecholamines.

  1963cited by this paper
• Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver.

  1962cited by this paper
• Influence of Some Factors on Development of Experimental Cholesterol Atherosclerosis

  1958cited by this paper

• The Arrhythmogenicity of Sotalol and its Role in Heart Failure: A Literature Review

  2023cites this paper
• The Role of Sarcoplasmic Reticulum in the Protect ive Effect of Class I I I Drugs Against Ca

  2010cites this paper
• Remodelling of cardiac gap junction connexin 43 and arrhythmogenesis.

  2007cites this paper
• Sotalol: the mechanism of its antiarrhythmic-defibrillating effect.

  2006cites this paper
• The Protective effect ofd-sotalol against hypoxia-induced myocardial uncoupling

  2005cites this paper
• Influence of a new propranolol analogue on the rabbit myocardium in vitro.

  2004cites this paper
• Factors determining spontaneous ventricular defibrillation.

  2001cites this paper
• Factors Determining Spontaneous Ventricular Defibrillation

  2001cites this paper
• Modulation of cAMP level by tedisamil in guinea pig heart

  2000cites this paper
• Are the antiarrhythmic-defibrillating effects of D-sotalol due to or despite the prolongation of the action potential duration?

  1999cites this paper
• Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.

  1998cites this paper
• Sotalol Is More Powerful Than Propranolol in Suppressing Complex Ventricular Arrhythmias

  1997cites this paper
• Sotalol: From “Just Another Beta Blocker” to “The Prototype of Class III Antidysrhythmic Compound”

  1995cites this paper
• Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.

  1995cites this paper
• Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.

  1993cites this paper
• Hemodynamics effects of oral sotalol during both sinus rhythm and atrial fibrillation

  1993cites this paper
• Inotropic and haemodynamic effects of d- and d,l-sotalol: comparison with other antiarrhythmics.

  1993cites this paper
• Sotalol

  1993cites this paper
• Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.

  1993cites this paper
• Antiarrhythmic Actions of DL‐Sotalol in Ventricular and Supraventricular Arrhythmias

  1992cites this paper
• Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.

  1992cites this paper
• Effects of the New Class‐III Antiarrhythmic Drug D‐Sotalol on Contractile Function of Postischemic Myocardium

  1991cites this paper
• Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium

  1991cites this paper
• Cardiac Electrophysiologic and Inotropic Actions of New and Potent Methanesulfonanilide Class III Antiarrhythmic Agents in Anesthetized Dogs

  1991cites this paper
• Experimentelle In-vivo-Untersuchungen zur Hämodynamik von Antiarrhythmika

  1990cites this paper
• Plasma Concentrations and Haemodynamic Effects of d-Sotalol after β-Blockade in Dogs

  1990cites this paper
• Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: particular reference to sotalol.

  1990cites this paper
• Plasma concentrations and haemodynamic effects of d-sotalol after beta-blockade in dogs.

  1990cites this paper
• Hemodynamic effects of antiarrhythmic drugs: negative inotropy versus influence on peripheral circulation.

  1989cites this paper
• Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.

  1989cites this paper
• Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

  1987cites this paper
• Sotalol: a beta blocker with unique antiarrhythmic properties.

  1987cites this paper
• Correlation between effects of hydralazine on force and on the adenyl cyclase system of ventricular myocardium in dogs and cats.

  1986cites this paper
• Sotalol, a Pure Beta‐Adrenergic Blocking Agent for Treatment of Essential Hypertension and Other Cardiovascular Diseases

  1979cites this paper
• Sotalol/Hydrochlorothiazide in Geriatric Hypertensive Patients

  1979cites this paper
• Enhanced cardiac response to catecholamines in physically trained cats.

  1978cites this paper
• Effect of propranolol on bile acid- and cholera enterotoxin-stimulated cAMP and secretion in rabbit intestine.

  1977cites this paper
• Prolonged contraction duration in aged myocardium.

  1975cites this paper
• Positive inotropic effects of methoxamine: evidence for alpha-adrenergic receptors in ventricular myocardium.

  1975cites this paper
• Effect of norepinephrine on myocardial intracellular hydrogen ion concentration.

  1975cites this paper
• (3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors.

  1974cites this paper
• Effects of methylprednisolone administration in acute myocardial infarction.

  1974cites this paper
• Interaction of phentolamine and noradrenaline on myocardial contractility and adenyl cyclase activity.

  1974cites this paper
• Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle.

  1973cites this paper
• Effects of D- and DL-Propranolol on Myocardial Adenyl Cyclase Activity 1

  1973cites this paper